关注
Prashant Bajpai
Prashant Bajpai
Postdoctoral Fellow, Emory Vaccine Center, Emory University
在 emory.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
ACE2 protein expression in lung tissues of severe COVID-19 infection
A Gheware, A Ray, D Rana, P Bajpai, A Nambirajan, S Arulselvi, P Mathur, ...
Scientific reports 12 (1), 4058, 2022
612022
Altered expression and editing of miRNA-100 regulates iTreg differentiation
V Negi, D Paul, S Das, P Bajpai, S Singh, A Mukhopadhyay, A Agrawal, ...
Nucleic Acids Research 43 (16), 8057-8065, 2015
572015
Microbe-mitochondrion crosstalk and health: an emerging paradigm
P Bajpai, A Darra, A Agrawal
Mitochondrion 39, 20-25, 2018
512018
Structural insights for neutralization of Omicron variants BA. 1, BA. 2, BA. 4, and BA. 5 by a broadly neutralizing SARS-CoV-2 antibody
S Kumar, A Patel, L Lai, C Chakravarthy, R Valanparambil, ES Reddy, ...
Science advances 8 (40), eadd2032, 2022
302022
Broadly neutralizing antibodies to SARS-CoV-2 provide novel insights into the neutralization of variants and other human coronaviruses
P Bajpai, V Singh, A Chandele, S Kumar
Frontiers in Cellular and Infection Microbiology 12, 928279, 2022
112022
Contrasting behavior between the three human monocyte subsets in dengue pathophysiology
D Maheshwari, K Saini, P Singh, M Singla, K Nayak, C Aggarwal, ...
IScience 25 (6), 2022
102022
Severe disease during both primary and secondary dengue virus infections in pediatric populations
C Aggarwal, H Ahmed, P Sharma, ES Reddy, K Nayak, M Singla, ...
Nature medicine 30 (3), 670-674, 2024
72024
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response
A Patel, S Kumar, L Lai, C Chakravarthy, R Valanparambil, ES Reddy, ...
Structure 31 (7), 801-811. e5, 2023
32023
Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody
S Kumar, S Singh, A Chatterjee, P Bajpai, S Sharma, S Katpara, R Lodha, ...
Iscience 26 (9), 2023
22023
B cell repertoire sequencing of HIV-1 pediatric elite-neutralizers identifies multiple broadly neutralizing antibody clonotypes
S Kumar, P Bajpai, C Joyce, SK Kabra, R Lodha, DR Burton, B Briney, ...
Frontiers in Immunology 15, 1272493, 2024
12024
Functional and transcriptional heterogeneity within the massively expanding HLADR+CD38+ CD8 T cell population in acute febrile dengue patients
P Singh, P Bajpai, D Maheshwari, YM Chawla, K Saini, ES Reddy, ...
Journal of Virology 97 (11), e00746-23, 2023
12023
Prediction of human protein interactome of dengue virus non-structural protein 5 (NS5) and its downstream immunological implications
P Bhatnagar, P Bajpai, J Shrinet, MK Kaja, A Chandele, R Sitaraman
3 Biotech 13 (6), 180, 2023
2023
Recognition determinants of broad and potent HIV-1 neutralization by an affinity matured antibody from a pediatric elite-neutralizer
S Kumar, S Singh, A Chatterjee, P Bajpai, S Sharma, S Katpara, R Lodha, ...
bioRxiv, 2023.01. 19.524673, 2023
2023
Transcriptional profiles of functionally distinct HLADR+CD38+ CD8 T cells subsets from acute febrile dengue patients
P Singh, P Bajpai, D Maheshwari, YM Chawla, K Gottimukkala, ES Reddy, ...
bioRxiv, 2022.09. 09.507387, 2022
2022
Structural insights for neutralization of BA. 1 and BA. 2 Omicron variants by a broadly neutralizing SARS-CoV-2 antibody
S Kumar, A Patel, L Lai, C Chakravarthy, R Valanparambil, ...
bioRxiv, 2022.05. 13.491770, 2022
2022
Structural insights for neutralization of BA. 1 and BA. 2 Omicron variants by a broadly neutralizing SARS-CoV-2 antibody (preprint)
S Kumar, A Patel, L Lai, C Chakravarthy, R Valanparambil, ...
2022
ACE2 Expression in Lungs of Severe COVID-19 Infection: A Study on Minimally Invasive Post-mortem Tissue Samples
A Gheware, A Ray, D Rana, P Bajpai, A Nambirajan, S Arulselvi, P Mathur, ...
2021
ACE2 Expression in Lungs of Severe COVID-19 Infection: A Study on Minimally Invasive Post-mortem Tissue Samples (preprint)
A Gheware, A Ray, D Rana, P Bajpai, A Nambirajan, S Arulselvi, P Mathur, ...
2021
系统目前无法执行此操作,请稍后再试。
文章 1–18